Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis From the Enroll-Hd Database

Movement Disorders Clinical Practice - United States
doi 10.1002/mdc3.12706
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

Tetrabenazine as Anti-Chorea Therapy in Huntington Disease: An Open-Label Continuation Study. Huntington Study Group/Tetra-Hd Investigators

BMC Neurology
MedicineNeurology
2009English

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-Hd Database

Frontiers in Neurology
Neurology
2018English

Reply to Olanzapine/Risperidone and Diabetes Risk

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2003English

Huntington-Krankheit Und Chorea Minor

Neurologie up2date
2019English

An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients

Archives of General Psychiatry
2002English

The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone

The Primary Care Companion to The Journal of Clinical Psychiatry
2000English

CAG-repeat Length and the Age of Onset in Huntington Disease (HD): A Review and Validation Study of Statistical Approaches

American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics
PsychiatryMolecular NeuroscienceMental HealthGeneticsCellular
2009English

A Classification System to Guide Physical Therapy Management in Huntington Disease

Journal of Neurologic Physical Therapy
GerontologyPhysical TherapySports TherapyGeriatricsMedicineNeurologyRehabilitation
2017English

Huntington Disease: DNA Analysis in Brazilian Population

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy